HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Henkel “Sustainability” Focuses On REACH, Renewable Ingredients

This article was originally published in The Rose Sheet

Executive Summary

Henkel is pushing EU lawmakers to develop a "pragmatic" approach to implementing its REACH chemicals program, the company states in its 2006 Sustainability Report, released March 22

You may also be interested in...



Everybody Wins: Corporate Responsibility Programs That Also “Sell Soap”

Personal care companies increasingly are developing programs that not only reduce their impact on the environment and give back to the local and global community, but award benefits to the business as well, according to Jennifer Nash, executive director of the corporate responsibility initiative at Harvard University's John F. Kennedy School of Government

REACH Passes European Parliament, Heads For Council And June ’07 Start

The European Parliament (EP) adopted the Registration, Evaluation Authorization & Restriction of Chemicals legislation Dec. 13 by a vote of 529 in favor, 98 against and 24 abstentions

Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD

A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014625

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel